FBXO8 and colorectal cancer: proposed a novel tumor-suppressive mechanism for FBXO8, showing that it upregulates epithelial and stem cell markers linked to tumor cell dormancy while downregulating mesenchymal and proliferation markers, thereby promoting metastatic dormancy in colorectal cancer cells (45).